Stephanie McMahon Among The Insiders Selling Shares Of Their Companies

Let’s move from the squared circle to the hospital room, a room that Omnicell, Inc. (NASDAQ:OMCL) helps make more efficient with its healthcare solutions and management systems. The company’s EVP of Field Operations, Christopher Drew sold 25,000 shares on August 11 at $35.89 per share. A day earlier, EVP and General Counsel Dan Johnston sold 7,700 shares total in three transactions at an average price of about $36.05. While Omnicell is up by over 8% this year, the sales don’t necessarily come at an ideal time, as shares have lost over 10% since late July when the company announced its second quarter results, which missed the Zacks Consensus Estimate on both the top and bottom lines by a notable amount. The miss comes after two big earnings beats in the prior two quarters, which propelled the stock to a 35% gain between the middle of October 2014, and the middle of April of this year. Ken Fisher’s Fisher Asset Management holds 550,000 shares of Omnicell, Inc. (NASDAQ:OMCL) as of June 30.

Finally, we move from the hospital to the factory floor, where Gentherm Inc (NASDAQ:THRM) churns out thermal comfort products, primarily for the automotive industry. Three different company insiders have sold shares this week, with President and CEO Daniel Coker selling 43,170 shares in two transactions, Director Francois Castaing selling 5,000 shares, and CFO, VP of Finance, and Treasurer, Barry Steele selling 6,528 shares. Gentherm Inc (NASDAQ:THRM) is in the midst of another strong year, up by more than 32%, after gaining more than 150% during 2013 and 2014. The automotive thermal system market is anticipated to grow rapidly throughout the rest of the decade, which suggests there could be plenty of growth yet found in the shares of Gentherm. Drew Cupps’ Cupps Capital Management has a position of 266,635 shares of Gentherm as of June 30, having sold off 17% of its position in the second quarter.

Disclosure: None